[quick news] the draft biosafety law of October 24, 2019 is intended to punish the misuse of biotechnology

On October 21, the draft biosafety law will be submitted to the 14th session of the Standing Committee of the 13th National People's Congress for deliberation for the first time In view of the lack of corresponding punishment provisions for the behaviors and events of biotechnology misuse in the previous period, the draft clarifies the corresponding responsibilities and penalties, and fills the legal gap It is reported that the scope of the draft regulation and adjustment is divided into eight categories: first, prevention and control of major emerging infectious diseases, animal and plant epidemics; second, research, development and application of biotechnology; third, protection of laboratory biological safety; fourth, protection of China's biological resources and human genetic resources; fifth, prevention of alien species invasion and protection of biological diversity; sixth, response to microbial resistance; The seventh is to prevent bioterrorism; the eighth is to prevent the threat of biological weapons Http://digitalpaper.stdaily.com/http_www.kjrb.com/kjrb/html/2019-10 / 23 / content_ HTM? Div = - 1 lung cancer project of China cancer gene map plan started Organized by the national human genetic resources center, the lung cancer project of China tumor gene map program, which is jointly organized by the hospitals with the characteristics of clinical diagnosis and treatment of single tumor diseases and high-tech enterprises, was officially launched The project leader, Professor Zhi Xiuyi, director of lung cancer diagnosis and treatment center of Capital Medical University, and Gao Huafang, director of science and Technology Institute of national health and Health Commission / national human genetic resources center attended the launching ceremony According to Zhi Xiuyi, the China cancer gene map program is one of the brand projects of "healthy China 2030", and will recruit 2500 people across the country in a multi center way The purpose of this study was to map the gene map of lung cancer in China, to provide scientific basis for the establishment of standardized detection and analysis process, and to explore lung cancer targeting, immunotherapy efficacy, prognosis molecular markers, etc Http://news.scienceet.cn/htmlnews/2019/10/431762.shtm gene editing has a good prospect of application, but it is unrealistic to change DNA on its own Recently, the United States issued the first law to directly supervise CRISPR, calling for consumers to stop buying and using relevant toolkits on their own By 2025, the global gene editing market will reach 8.1 billion US dollars Recently, California introduced a bill for CRISPR gene editing technology, which prohibits the sale of gene editing kits in California unless the seller prominently warns consumers not to use the kits on themselves This is the first direct regulation of CRISPR in the United States The Act states that no person shall sell a genetic editing kit in California unless permitted by federal law, unless the seller places a clearly visible label on its website and on the package of the kit indicating that the kit cannot be used by itself The bill will come into effect in January 2020 Http://digitalpaper.stdaily.com/http_www.kjrb.com/kjrb/html/2019-10 / 23 / content_ HTM? Div = - 1 the 17th International immunology Congress, CO sponsored by the international immunology Federation and the Chinese immunology society, was held in Beijing on October 20 The International Congress of Immunology (ICI) is the official Congress of the International Federation of immunology Societies (IUIS) ICI is the Academic Congress with the highest specification, the largest scale and the widest coverage in the field of international immunology, which is held every three years This is the first time the conference has been held in China This Congress has set up 12 conference themes, including innate immunity and infection, human immunology and vaccine, tumor immunology and immunotherapy, and new immunology technology It has organized three Nobel Prize reports on Physiology or medicine, six keynote reports, 48 special reports of the Congress, 198 special sub conference reports, and 416 branch reports Cao Xuetao, academician of Chinese Academy of engineering and President of Nankai University, said that the meeting provided a platform for the immunology community to jointly discuss the latest research and research trends in the field of immunology, promoted exchanges and cooperation between China's immunology and the world, and effectively promoted the development of immunology in China Http://news.scienceet.cn/htmlnews/2019/10/431708.shtm Chinese scientists first revealed the new mechanism of "gastrointestinal stromal tumor" to help precision medicine According to the information released by Shanghai Institute of nutrition and health, Chinese Academy of Sciences, Wang Yuexiang's team of the Institute has for the first time analyzed the new mechanism of malignant progress of "gastrointestinal stromal tumor" in the world, and the relevant research results of translational medicine were published online in the international academic journal proc Natl Acad SCI USA (Proceedings of the American Academy of Sciences) in the early morning of Beijing time on Tuesday This achievement was supported by NSFC, the national key R & D program of the Ministry of science and technology, the basic key projects of Shanghai Science and Technology Commission, the project of Chinese Academy of Sciences, etc., as well as the public technology platform, animal platform of Shanghai Institute of nutrition and health, and the transformation medicine platform of Changzheng Hospital http://www.chinanews.com/jk/2019/10-22/8985808.shtml